Verona Pharma (VRNA)
(Delayed Data from NSDQ)
$21.07 USD
-1.41 (-6.27%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $21.09 +0.02 (0.09%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, Verona Pharma (VRNA) reported earnings of -$0.32 per share, missing the Zacks Consensus Estimate of -$0.24 per share. This reflects a negative earnings surprise of 33.33%. Look out for VRNA's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year decrease of 218.18%.
Earnings History
Price & Consensus
Zacks News for VRNA
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
VRNA: What are Zacks experts saying now?
Zacks Private Portfolio Services